These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8272744)

  • 21. [Antiretroviral treatment in human immunodeficiency virus infection].
    Blum L; Bachmeyer C
    Ann Dermatol Venereol; 1997; 124(9):641-54. PubMed ID: 9739932
    [No Abstract]   [Full Text] [Related]  

  • 22. Study results at a glance.
    AIDS Alert; 1995 Nov; 10(11):134. PubMed ID: 11362922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anti-HIV therapy (1987-1994): from nothing to confusion].
    Lissen E
    Med Clin (Barc); 1995 Apr; 104(12):463-7. PubMed ID: 7739285
    [No Abstract]   [Full Text] [Related]  

  • 24. AZT studies reinforce benefits of combination.
    AIDS Alert; 1995 Jan; 10(1):11-2. PubMed ID: 11362167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What we know about anti-HIV drugs.
    Treat Rev; 1995 May; (no 18):3-4. PubMed ID: 11362592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Confirmation for combination AIDS therapy.
    Science; 1995 Oct; 270(5233):33. PubMed ID: 7569948
    [No Abstract]   [Full Text] [Related]  

  • 27. Didanosine (DDI) alone is now considered the first-line therapy for symptomatic children infected with the human immunodeficiency virus (HIV).
    J Am Osteopath Assoc; 1996 Jun; 96(6):339. PubMed ID: 8690619
    [No Abstract]   [Full Text] [Related]  

  • 28. Study shows two drugs are best for HIV infection.
    Dillner L
    BMJ; 1995 Sep; 311(7009):827. PubMed ID: 7580483
    [No Abstract]   [Full Text] [Related]  

  • 29. Antiretroviral therapy and medical management of the human immunodeficiency virus-infected child. Working Group on Antiretroviral Therapy: National Pediatric HIV Resource Center.
    Pediatr Infect Dis J; 1993 Jun; 12(6):513-22. PubMed ID: 8393969
    [No Abstract]   [Full Text] [Related]  

  • 30. ACTG 175 and Delta.
    Torres G
    GMHC Treat Issues; 1995 Oct; 9(10):2-3. PubMed ID: 11362915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Results of two studies: Delta I/II and ACTG 175].
    Biehler GV
    Sidahora; 1996 Dec-1997 Jan; ():37-40. PubMed ID: 11363441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New trials reach same conclusion: two drugs are better than AZT alone.
    AIDS Alert; 1995 Nov; 10(11):133-6. PubMed ID: 11362921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3TC/AZT: just another combination.
    GMHC Treat Issues; 1995 Dec; 9(12):2. PubMed ID: 11362997
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A bend in the road--implications of ACTG 175 and Delta trials.
    Hirsch MS; Yeni P
    Antivir Ther; 1996 Jan; 1(1):6-8. PubMed ID: 11322260
    [No Abstract]   [Full Text] [Related]  

  • 35. [Resistance and combined use of anti-HIV drugs].
    Rosenthal C
    Rev Soc Bras Med Trop; 1995; 28 Suppl 2():9-18. PubMed ID: 8693153
    [No Abstract]   [Full Text] [Related]  

  • 36. Back to the nukes.
    Smart T
    GMHC Treat Issues; 1996 Feb; 10(2):6-7. PubMed ID: 11363383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Closing the circle on HIV--or not.
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1995 Oct; 1(9):10-4, 17-29 contd. PubMed ID: 11362964
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antiviral treatment].
    Hermans P
    Acta Urol Belg; 1993; 61(1-2):593-8. PubMed ID: 7685982
    [No Abstract]   [Full Text] [Related]  

  • 39. [Combination therapy of HIV].
    Gerstoft J; Pedersen BK
    Ugeskr Laeger; 1996 Jan; 158(2):175-6. PubMed ID: 8553492
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacotherapy of HIV. APhA Editorial Board on Pharmaceutical Care for Patients with HIV Infection.
    Am Pharm; 1994 Feb; NS34(2):60-9; quiz 69-70. PubMed ID: 8166046
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.